There are currently 283 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Cancer participants are California, Texas, New York and Florida.
TEMPUS ARIES: a Biobank Registry Platform Study in Oncology
NCT06207032
Recruiting
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
02/25/2025
Locations: Alabama Oncology, Birmingham, Alabama +23 locations
Conditions: Cancer
Register for Updates
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
NCT05681026
Recruiting
To develop and measure the effects of a culturally sensitive yoga program for inpatients
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/25/2025
Locations: M D Anderson Cancer Center, Houston, Texas
Conditions: Hematopoietic Stem Cell Transplantation, Cancer
Register for Updates
Ex Onc SLED: a Study Utilizing a Weighted Sled for Horizontal Resistance Training
NCT06610396
Recruiting
This protocol seeks to analyze patient adherence and outcomes after monitored exercise sessions utilizing primarily weighted sled pushes and pulls for linearly progressed resistance training of individuals who have been diagnosed with cancer.
Gender:
ALL
Ages:
Between 20 years and 89 years
Trial Updated:
02/24/2025
Locations: Allegheny General Hospital, Pittsburgh, Pennsylvania
Conditions: Cancer
Register for Updates
Autoimmunity After Checkpoint Blockade
NCT04119713
Recruiting
The purpose of this study is to better understand how the treatment of cancer with immune checkpoint inhibitors (ICI) leads to the development of autoimmunity. Specifically, we wish to understand the genetics and immune system features that cause a subset of cancer patients treated with checkpoint inhibitor therapy to develop an immune-related adverse event (irAE).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/24/2025
Locations: University of Pennsylvania - Abramson Cancer Center, Philadelphia, Pennsylvania
Conditions: Autoimmunity, Cancer, Immunotoxicity, Oncology
Register for Updates
BfedBwell Optimization Pilot
NCT06184256
Recruiting
Using the Multiphase Optimization Strategy (MOST) framework, an engineering-based approach to efficiently and systematically develop, optimize, and evaluate behavioral interventions, this study will test three components: (1) 1:1 counseling with a registered dietitian, (2) behavioral skills development, and (3) group support for delivery alongside a core nutrition curriculum within a clinical exercise oncology program.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
02/21/2025
Locations: University of Colorado Cancer Center, Aurora, Colorado
Conditions: Survivorship, Cancer
Register for Updates
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
NCT06083324
Recruiting
This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.
Gender:
ALL
Ages:
Between 20 years and 89 years
Trial Updated:
02/19/2025
Locations: AHN CI Exercise Oncology and Resiliency Center, Pittsburgh, Pennsylvania
Conditions: Cancer
Register for Updates
Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
NCT05823740
Recruiting
The primary objective of this study is to evaluate the feasibility and acceptability of obtaining repeated measurements of lean muscle mass, physical function, and biological aging in children receiving active cancer therapy. The secondary objective is to evaluate the feasibility of using the D3-creatine dilution method (D3Cr) to measure skeletal muscle mass in children with cancer. Assessments will be collected at diagnosis, once during active treatment, and end of treatment in coordination wi... Read More
Gender:
ALL
Ages:
Between 8 years and 21 years
Trial Updated:
02/17/2025
Locations: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Conditions: Cancer, Malignant Neoplasm
Register for Updates
Galleri in the Medicare Population
NCT05673018
Recruiting
This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek to enroll approximately 20% of the study participants from under-represented minority populations (e.g., racial / ethnic minority groups, socioeconomically disadvantaged populations, rural populations).
Gender:
ALL
Ages:
50 years and above
Trial Updated:
02/12/2025
Locations: Long Beach Memorial, Long Beach, California +4 locations
Conditions: Cancer
Register for Updates
Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
NCT00760656
Recruiting
Childhood cancer predisposes to health risks that may not become apparent until many years after completion of therapy. The SJLIFE protocol is designed to establish a lifetime cohort of childhood cancer survivors treated at St. Jude Children's Research Hospital to facilitate evaluation of health outcomes in aging adults surviving pediatric cancer. The study focuses on the following Primary and secondary objectives: * To establish a lifetime cohort of childhood cancer survivors treated at St. J... Read More
Gender:
ALL
Ages:
5 years and above
Trial Updated:
02/12/2025
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee
Conditions: Cancer
Register for Updates
Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
NCT05829824
Recruiting
This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/12/2025
Locations: University of California, San Francisco, San Francisco, California
Conditions: Cancer, Tobacco Dependence, Tobacco Use Cessation
Register for Updates
TREC@TAMU Cancer Prevention Registry and Repository
NCT06826014
Recruiting
This study collects health and genetic information to implement cancer prevention and treatment strategies.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/11/2025
Locations: Texas A&M Family Care, Bryan, Texas
Conditions: Cancer, Genetics, Disease, Diet, Lifestyle Factors
Register for Updates
Implementation of a Pharmacist-Based, Post-Chemotherapy Follow-up Clinic
NCT05965206
Recruiting
The purpose of this study is to determine the impact of pharmacists on reducing chemotherapy-related side effects by providing education before and after patients receive intravenous chemotherapy at one of Cedars-Sinai outpatient infusion centers. Participants will be interviewed via telephone within 7 business days after receiving intravenous chemotherapy from the outpatient cancer center infusion clinic.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/10/2025
Locations: Cedars-Sinai Medical Center, Los Angeles, California
Conditions: Cancer
Register for Updates